Thiram, an inhibitor of 11ß-hydroxysteroid dehydrogenase type 2, enhances the inhibitory effects of hydrocortisone in the treatment of osteosarcoma through Wnt/β-catenin pathway

BACKGROUND: The anti-osteosarcoma effects of hydrocortisone and thiram, an inhibitor of type 2 11ß-hydroxysteroid dehydrogenase (11HSD2), have not been reported. The purpose of this study was to investigate the effects of hydrocortisone alone or the combination of hydrocortisone with thiram on osteo...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, You, Li, Nanjing, Li, He, Chen, Maojia, Jiang, Wei, Guo, Wenhao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10045229/
https://www.ncbi.nlm.nih.gov/pubmed/36978114
http://dx.doi.org/10.1186/s40360-023-00655-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10045229/
https://www.ncbi.nlm.nih.gov/pubmed/36978114
http://dx.doi.org/10.1186/s40360-023-00655-0

Ejemplares similares